This site is intended for healthcare professionals only
LoginRegister
Parliamentary Panel Slams CDSCO for Slow Drug Approvals, Calls for Conditional Licensing in 45 DaysParliamentary Panel Slams CDSCO for Slow Drug Approvals, Calls for Conditional Licensing in 45 Days
India produces 60 percent of the world vaccines: ICMR former chiefIndia produces 60 percent of the world vaccines: ICMR former chief
Racket manufacturing fake medicines busted, factory owner heldLucknow: Two arrested for shipment of banned medicines to US
Certain medicines with misleading claims seized in TelanganaCertain medicines with misleading claims seized in Telangana
Unichem Labs Roha facility gets 3 USFDA observationsJubilant Pharmova arm Salisbury facility gets USFDA EIR
Shilpa Pharma to infuse USD 2 million in Alveolus BioZydus Lifesciences venture capital arm injects in Illexcor Therapeutics to advance novel oral...
JnJ seeks indication extension of Akeega from EMA for adults with metastatic hormone-sensitive prostate cancer, HRR gene alterationsJohnson and Johnson Wins Rs 3.34 Crore Lawsuit Against Fake SURGICEL, ETHICON Sellers
Submit More Data:  CDSCO Panel tells Boehringer Ingelheim on Veterinary Drug AfoxolanerSubmit More Data:  CDSCO Panel tells Boehringer Ingelheim on Veterinary Drug Afoxolaner
CDSCO Panel Accepts Phase I Trial Data for Intas Denosumab BiosimilarIntas Pharmaceuticals Gets CDSCO Panel Nod To study Bevacizumab Solution for Injection
Cardiac, GI Power Indian Pharma Markets 7.5% March SurgeIndian Pharma market to expand by 8-9 percent in FY26: Report
Zydus Lifesciences receives tentative approval from USFDA for Chronic lymphocytic leukaemia drug IbrutinibZydus Lifesciences bags USFDA approval for urinary tract infections drug
48 projects approved to avoid disruption in critical APIs supplyIndian pharma exports secured 11th position globally in 2023, says Minister
X